Home >AIM and small-cap hubInsight and IdeasOverviewFree updatesQuick start fundsii Super 60Model PortfoliosWinter PortfoliosCoronavirus2020 outlookQuarterly outlookTrading tips and ideasAIM and small-cap hubInsider videosii PodcastsHistorical recommendationsMeet the expertsAIM and small-cap hub Get the lowdown on smaller company shares and all that matters on the junior market. 31 MarchStockwatch: Betting on one of life’s certainties It might make investors uncomfortable, but some stocks will benefit from Covid-19. Is this one of them?by Edmond Jackson31 MarchTwo winning stocks in the race to cure Covid-19Shares in Johnson & Johnson and AIM-listed Novacyt have surged as both firms fight coronavirus.by Graeme Evans27 MarchStockwatch: Rescuing others should boost this shareDespite uncertainty, companies like this one could see a big uptick in business over the next few years.by Edmond Jackson20 MarchAIM dividends: Who’s cutting and who’s raising the payoutOur award-winning AIM writer identifies companies who may cut the dividend and those boosting income.by Andrew Hore20 MarchThis AIM star is my kind of companyAmid the chaos, this university spin-out is a candidate for long-term investment at a decent price. by Richard Beddard13 MarchAIM stocks for a recession?Think a global recession is possible? Our award-winning AIM writer has found some potential boltholes.by Andrew HoreRegister to receive free daily market commentary, insight and analysis from our award-winning editorial team.
31 MarchStockwatch: Betting on one of life’s certainties It might make investors uncomfortable, but some stocks will benefit from Covid-19. Is this one of them?by Edmond Jackson
31 MarchTwo winning stocks in the race to cure Covid-19Shares in Johnson & Johnson and AIM-listed Novacyt have surged as both firms fight coronavirus.by Graeme Evans
27 MarchStockwatch: Rescuing others should boost this shareDespite uncertainty, companies like this one could see a big uptick in business over the next few years.by Edmond Jackson
20 MarchAIM dividends: Who’s cutting and who’s raising the payoutOur award-winning AIM writer identifies companies who may cut the dividend and those boosting income.by Andrew Hore
20 MarchThis AIM star is my kind of companyAmid the chaos, this university spin-out is a candidate for long-term investment at a decent price. by Richard Beddard
13 MarchAIM stocks for a recession?Think a global recession is possible? Our award-winning AIM writer has found some potential boltholes.by Andrew Hore